Hemoglobin levels and 30-day mortality in patients after myocardial infarction

E Lipsic, ICC van der Horst, AA Voors, P van der Meer, MWN Nijsten, WH van Gilst, DJ van Veldhuisen*, F Zijlstra

*Corresponding author voor dit werk

OnderzoeksoutputAcademicpeer review

71 Citaten (Scopus)

Samenvatting

Background: Anemia is an independent risk factor for cardiovascular (CV) outcomes in patients with coronary artery disease and heart failure. However, the effect of hemoglobin levels on short-term CV mortality in patients with acute myocardial infarction (MI) remains unclear.

Methods: In a retrospective study we analyzed 1841 consecutive patients admitted with the diagnosis of acute MI. The primary end-point of the study was 30-day mortality. Patients were categorized according to the hemoglobin level on admission (10 g/dl or less, or greater than 10 g/dl).

Results: The overall 30-day mortality was 10.3%. The mortality was 21.6% in patients with hemoglobin levels on admission 10 g/dl (p <0.001). Multivariate logistic regression analysis showed, that lower hemoglobin concentration is an independent predictor of 30-day mortality, when adjusted for other risk factors (HR 1.76, CI 1.08-2.85; p = 0.02).

Conclusions: Lower levels of hemoglobin are associated with higher short-term mortality in patients with acute MI. Specific therapeutic strategies in anemic patients with MI should be further considered. (c) 2005 Elsevier Ireland Ltd. All rights reserved.

Originele taal-2English
Pagina's (van-tot)289-292
Aantal pagina's4
TijdschriftInternational Journal of Cardiology
Volume100
Nummer van het tijdschrift2
DOI's
StatusPublished - 20-apr.-2005

Vingerafdruk

Duik in de onderzoeksthema's van 'Hemoglobin levels and 30-day mortality in patients after myocardial infarction'. Samen vormen ze een unieke vingerafdruk.

Citeer dit